169 related articles for article (PubMed ID: 15004330)
1. Overexpression of ubiquilin decreases ubiquitination and degradation of presenilin proteins.
Massey LK; Mah AL; Ford DL; Miller J; Liang J; Doong H; Monteiro MJ
J Alzheimers Dis; 2004 Feb; 6(1):79-92. PubMed ID: 15004330
[TBL] [Abstract][Full Text] [Related]
2. Studies of the role of ubiquitination in the interaction of ubiquilin with the loop and carboxyl terminal regions of presenilin-2.
Ford DL; Monteiro MJ
Biochemistry; 2007 Jul; 46(30):8827-37. PubMed ID: 17614368
[TBL] [Abstract][Full Text] [Related]
3. Ubiquilin regulates presenilin endoproteolysis and modulates gamma-secretase components, Pen-2 and nicastrin.
Massey LK; Mah AL; Monteiro MJ
Biochem J; 2005 Nov; 391(Pt 3):513-25. PubMed ID: 15975090
[TBL] [Abstract][Full Text] [Related]
4. Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation.
Mah AL; Perry G; Smith MA; Monteiro MJ
J Cell Biol; 2000 Nov; 151(4):847-62. PubMed ID: 11076969
[TBL] [Abstract][Full Text] [Related]
5. Dimerization of ubiquilin is dependent upon the central region of the protein: evidence that the monomer, but not the dimer, is involved in binding presenilins.
Ford DL; Monteiro MJ
Biochem J; 2006 Nov; 399(3):397-404. PubMed ID: 16813565
[TBL] [Abstract][Full Text] [Related]
6. Presenilin overexpression arrests cells in the G1 phase of the cell cycle. Arrest potentiated by the Alzheimer's disease PS2(N141I)mutant.
Janicki SM; Monteiro MJ
Am J Pathol; 1999 Jul; 155(1):135-44. PubMed ID: 10393846
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease-associated ubiquilin-1 regulates presenilin-1 accumulation and aggresome formation.
Viswanathan J; Haapasalo A; Böttcher C; Miettinen R; Kurkinen KM; Lu A; Thomas A; Maynard CJ; Romano D; Hyman BT; Berezovska O; Bertram L; Soininen H; Dantuma NP; Tanzi RE; Hiltunen M
Traffic; 2011 Mar; 12(3):330-48. PubMed ID: 21143716
[TBL] [Abstract][Full Text] [Related]
8. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease.
Mathews PM; Cataldo AM; Kao BH; Rudnicki AG; Qin X; Yang JL; Jiang Y; Picciano M; Hulette C; Lippa CF; Bird TD; Nochlin D; Walter J; Haass C; Lévesque L; Fraser PE; Andreadis A; Nixon RA
Mol Med; 2000 Oct; 6(10):878-91. PubMed ID: 11126202
[TBL] [Abstract][Full Text] [Related]
9. Mapping the APP/presenilin (PS) binding domains: the hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction.
Pradier L; Carpentier N; Delalonde L; Clavel N; Bock MD; Buée L; Mercken L; Tocqué B; Czech C
Neurobiol Dis; 1999 Feb; 6(1):43-55. PubMed ID: 10078972
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of wild-type presenilin 2 or its familial Alzheimer's disease-associated mutant does not induce or increase susceptibility to apoptosis in different cell lines.
Gamliel A; Teicher C; Hartmann T; Beyreuther K; Stein R
Neuroscience; 2003; 117(1):19-28. PubMed ID: 12605888
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression.
Sato N; Urano F; Yoon Leem J; Kim SH; Li M; Donoviel D; Bernstein A; Lee AS; Ron D; Veselits ML; Sisodia SS; Thinakaran G
Nat Cell Biol; 2000 Dec; 2(12):863-70. PubMed ID: 11146649
[TBL] [Abstract][Full Text] [Related]
12. Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest.
Janicki SM; Stabler SM; Monteiro MJ
Neurobiol Aging; 2000; 21(6):829-36. PubMed ID: 11124426
[TBL] [Abstract][Full Text] [Related]
13. Ubiquilin recruits Eps15 into ubiquitin-rich cytoplasmic aggregates via a UIM-UBL interaction.
Regan-Klapisz E; Sorokina I; Voortman J; de Keizer P; Roovers RC; Verheesen P; Urbé S; Fallon L; Fon EA; Verkleij A; Benmerah A; van Bergen en Henegouwen PM
J Cell Sci; 2005 Oct; 118(Pt 19):4437-50. PubMed ID: 16159959
[TBL] [Abstract][Full Text] [Related]
14. Interaction between presenilin 1 and ubiquilin 1 as detected by fluorescence lifetime imaging microscopy and a high-throughput fluorescent plate reader.
Thomas AV; Herl L; Spoelgen R; Hiltunen M; Jones PB; Tanzi RE; Hyman BT; Berezovska O
J Biol Chem; 2006 Sep; 281(36):26400-7. PubMed ID: 16815845
[TBL] [Abstract][Full Text] [Related]
15. Ubiquilin/Dsk2 promotes inclusion body formation and vacuole (lysosome)-mediated disposal of mutated huntingtin.
Chuang KH; Liang F; Higgins R; Wang Y
Mol Biol Cell; 2016 Jul; 27(13):2025-36. PubMed ID: 27170182
[TBL] [Abstract][Full Text] [Related]
16. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.
Walker ES; Martinez M; Brunkan AL; Goate A
J Neurochem; 2005 Jan; 92(2):294-301. PubMed ID: 15663477
[TBL] [Abstract][Full Text] [Related]
17. Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy.
Rothenberg C; Srinivasan D; Mah L; Kaushik S; Peterhoff CM; Ugolino J; Fang S; Cuervo AM; Nixon RA; Monteiro MJ
Hum Mol Genet; 2010 Aug; 19(16):3219-32. PubMed ID: 20529957
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein.
Tanahashi H; Tabira T
Hum Mol Genet; 2000 Sep; 9(15):2281-9. PubMed ID: 11001931
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of presenilin 2 inhibits protein synthesis.
Gamliel A; Teicher C; Michaelson DM; Pradier L; Hartmann T; Beyreuther K; Stein R
Mol Cell Neurosci; 2002 Jan; 19(1):111-24. PubMed ID: 11817902
[TBL] [Abstract][Full Text] [Related]
20. Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and beta-amyloid precursor protein.
Weidemann A; Paliga K; Dürrwang U; Czech C; Evin G; Masters CL; Beyreuther K
Nat Med; 1997 Mar; 3(3):328-32. PubMed ID: 9055862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
